Ring Therapeutics
About:
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Website: http://www.ringtx.com
Twitter/X: ring_tx
Top Investors: Alexandria Venture Investments, Invus, T. Rowe Price, UPMC Enterprises, Partners Investment
Description:
Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Founded by Flagship Pioneering, Ring is pioneering the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company is expanding the applications of gene therapy beyond gene replacement, enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.
$254M
$10M to $50M
Cambridge, Massachusetts, United States
2017-01-01
info(AT)ringtx.com
Avak Kahvejian, Erica Weinstein, Noubar Afeyan
101-250
2023-03-09
Private
© 2025 bioDAO.ai